Our reputation has been gained through the successful conduct of over 300 Early Phase Studies since inception in 2001, ranging from testing Anaesthetic agents to Zinamide interaction studies. The specialist areas in which we have really excelled over many years are Adaptive, Thorough-QT, Japanese Bridging Studies and Patient Recruitment – evident in the numerous peer-reviewed papers we have published.

UK's leading clinical research organisation

Our business ethos is unique: Our revenues serve the National Health Service and St George’s University of London, fund basic research, support charities or otherwise are reinvested in the business. Our business is sustainable, adaptive to change and is led by the same specialists who founded the business more than ten years ago.

All our sponsors are preferred clients. Richmond Pharmacology’s interaction with its sponsors is personal and truly strategic, generating enhanced value for drug developers and investors.

Our work is closely supervised throughout by the same senior specialists sponsors meet during the first consultation or bid defence. Our services span strategic consultancy and concept development through to final reporting, utilising our many years of experience and leading to successful clinical trials with meaningful results.

Work with our experts

Conduct your trial in a cost effective and timely manor

Get in touch today

Latest news

Dr Jorg Taubel attending ACCP in San Diego

05th Sep 2017

Dr Jorg Taubel will be attending the ACCP in San Diego, September 17-19, where he will be discussing his latest

Read more ›

DIA, Chicago 2017

23rd Jun 2017

Richmond Pharmacology is a frequent contributor and recognised thought leader for various scientific meetings

Read more ›

Richmond Pharmacology’s New London Bridge unit offers unrivalled access to patient recruitment

28th Apr 2017

Richmond Pharmacology has been settling into life in its New London Bridge Research Unit.

Read more ›